Clinical Trial Update: CMV-CTL for the Treatment of CMV Infection After HSCT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for CMV-CTL as a treatment for cytomegalovirus infection after hematopoietic stem cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections
• Hematological Disease

Drugs mentioned

• CMV-CTL

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Cytomegalovirus Infections, Hematological Disease | Phase 4 | Status: COMPLETED